$BCBP
BCB BANCORP INC

2024 Q4 Form 10-Q Financial Statement

#000122845424000012 Filed on November 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $48.63M
YoY Change -0.9%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $427.0K
YoY Change -14.6%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $25.58M
YoY Change 9.38%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $9.353M
YoY Change -0.69%
Income Tax $2.685M
% Of Pretax Income 28.71%
Net Earnings $6.193M
YoY Change -7.72%
Net Earnings / Revenue 12.74%
Basic Earnings Per Share $0.36
Diluted Earnings Per Share $0.36
COMMON SHARES
Basic Shares Outstanding 17.05M 17.04M
Diluted Shares Outstanding 17.06M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $243.1M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $25.45M
YoY Change 90.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.13M
YoY Change 22.5%
Other Assets $17.37M
YoY Change 4.01%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $3.614B
YoY Change -5.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $13.88M
YoY Change 4.35%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.88M
YoY Change 4.35%
LONG-TERM LIABILITIES
Long-Term Debt $67.04M
YoY Change 78.3%
Other Long-Term Liabilities $13.73M
YoY Change -10.24%
Total Long-Term Liabilities $80.78M
YoY Change 52.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.88M
Total Long-Term Liabilities $80.78M
Total Liabilities $3.286B
YoY Change -6.35%
SHAREHOLDERS EQUITY
Retained Earnings $141.8M
YoY Change 6.81%
Common Stock $200.6M
YoY Change 1.27%
Preferred Stock $29.76M
YoY Change 43.21%
Treasury Stock (at cost) $38.35M
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $328.1M
YoY Change
Total Liabilities & Shareholders Equity $3.614B
YoY Change -5.2%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $6.193M
YoY Change -7.72%
Depreciation, Depletion And Amortization $427.0K
YoY Change -14.6%
Cash From Operating Activities $43.53M
YoY Change 335.26%
INVESTING ACTIVITIES
Capital Expenditures $89.00K
YoY Change -70.33%
Acquisitions
YoY Change
Other Investing Activities $62.51M
YoY Change 64.93%
Cash From Investing Activities $62.42M
YoY Change 66.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -189.7M
YoY Change 175.72%
NET CHANGE
Cash From Operating Activities 43.53M
Cash From Investing Activities 62.42M
Cash From Financing Activities -189.7M
Net Change In Cash -83.75M
YoY Change 295.03%
FREE CASH FLOW
Cash From Operating Activities $43.53M
Capital Expenditures $89.00K
Free Cash Flow $43.44M
YoY Change 347.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Central Index Key
EntityCentralIndexKey
0001228454
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-50275
dei Entity Registrant Name
EntityRegistrantName
BCB Bancorp, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NJ
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-0065262
dei Entity Address Address Line1
EntityAddressAddressLine1
104-110 Avenue C
dei Entity Address City Or Town
EntityAddressCityOrTown
Bayonne
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07002
dei City Area Code
CityAreaCode
201
dei Local Phone Number
LocalPhoneNumber
823-0700
dei Security12b Title
Security12bTitle
Common Stock, no par value
dei Trading Symbol
TradingSymbol
BCBP
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17047974
CY2024Q3 us-gaap Cash And Due From Banks
CashAndDueFromBanks
12617000
CY2023Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
16597000
CY2024Q3 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
230506000
CY2023Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
262926000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
243123000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
279523000
CY2024Q3 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2023Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
98169000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
87769000
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
10133000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
9093000
CY2024Q3 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
250000
CY2023Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
1287000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
34693000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33608000
CY2024Q3 us-gaap Notes Receivable Net
NotesReceivableNet
3087914000
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
3279708000
CY2024Q3 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
24732000
CY2023Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
24917000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12008000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13057000
CY2024Q3 us-gaap Interest Receivable
InterestReceivable
16496000
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
16072000
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
17370000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
18213000
CY2024Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5253000
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5253000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13438000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12935000
CY2024Q3 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
75404000
CY2023Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
73407000
CY2024Q3 us-gaap Other Assets
OtherAssets
8745000
CY2023Q4 us-gaap Other Assets
OtherAssets
10428000
CY2024Q3 us-gaap Assets
Assets
3613770000
CY2023Q4 us-gaap Assets
Assets
3832397000
CY2024Q3 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
528089000
CY2023Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
536264000
CY2024Q3 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
2196491000
CY2023Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
2442816000
CY2024Q3 us-gaap Deposits
Deposits
2724580000
CY2023Q4 us-gaap Deposits
Deposits
2979080000
CY2024Q3 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
466424000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
472811000
CY2024Q3 us-gaap Subordinated Debt
SubordinatedDebt
67042000
CY2023Q4 us-gaap Subordinated Debt
SubordinatedDebt
37624000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
13878000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13315000
CY2024Q3 us-gaap Other Liabilities
OtherLiabilities
13733000
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
15512000
CY2024Q3 us-gaap Liabilities
Liabilities
3285657000
CY2023Q4 us-gaap Liabilities
Liabilities
3518342000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3000
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2528
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2528
CY2024Q3 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
29763000
CY2023Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
25043000
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20281945
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20138294
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17047974
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16904323
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
200605000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
198923000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
141770000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
135927000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5678000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7491000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3233971
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3233971
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
38347000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
38347000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
328113000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
314055000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3613770000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3832397000
CY2024Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
42857000
CY2023Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
44133000
CY2022Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
32302000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
130615000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
125666000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
87404000
CY2024Q3 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
303000
CY2023Q3 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
217000
CY2022Q3 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
173000
us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
905000
us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
587000
us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
379000
CY2024Q3 us-gaap Interest Income Other
InterestIncomeOther
994000
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
1045000
CY2022Q3 us-gaap Interest Income Other
InterestIncomeOther
1103000
us-gaap Interest Income Other
InterestIncomeOther
2975000
us-gaap Interest Income Other
InterestIncomeOther
3235000
us-gaap Interest Income Other
InterestIncomeOther
2990000
CY2024Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
4472000
CY2023Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
3672000
CY2022Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
822000
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
12861000
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
9168000
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
1812000
CY2024Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
48626000
CY2023Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
49067000
CY2022Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
34400000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
147356000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
138656000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
92585000
CY2024Q3 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
5686000
CY2023Q3 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
4556000
CY2022Q3 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
1169000
us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
16292000
us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
11900000
us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
2873000
CY2024Q3 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
146000
CY2023Q3 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
182000
CY2022Q3 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
113000
us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
464000
us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
443000
us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
331000
CY2024Q3 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
13670000
CY2023Q3 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
10922000
CY2022Q3 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
1087000
us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
43224000
us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
25849000
us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
2916000
CY2024Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
19502000
CY2023Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
15660000
CY2022Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
2369000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
59980000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
38192000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
6120000
CY2024Q3 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
6079000
CY2023Q3 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
7727000
CY2022Q3 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
1080000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
17549000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
20324000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
2701000
CY2024Q3 us-gaap Interest Expense
InterestExpense
25581000
CY2023Q3 us-gaap Interest Expense
InterestExpense
23387000
CY2022Q3 us-gaap Interest Expense
InterestExpense
3449000
us-gaap Interest Expense
InterestExpense
77529000
us-gaap Interest Expense
InterestExpense
58516000
us-gaap Interest Expense
InterestExpense
8821000
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
23045000
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
25680000
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
30951000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
69827000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
80140000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
83764000
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
2890000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
2205000
us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
7416000
us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
4177000
us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
-2575000
CY2024Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
20155000
CY2023Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
23475000
CY2022Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
30951000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
62411000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
75963000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
86339000
CY2024Q3 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
1196000
CY2023Q3 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
1349000
CY2022Q3 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
1251000
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
3530000
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
3889000
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
3678000
CY2024Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
652000
CY2023Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
466000
CY2022Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
646000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1998000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1154000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
2087000
CY2024Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
35000
CY2023Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
19000
CY2022Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
18000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
-4771000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
25000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
126000
CY2024Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
1132000
CY2023Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-494000
CY2022Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-559000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
1040000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-4390000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-5546000
CY2024Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
112000
CY2023Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
66000
CY2022Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
90000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
205000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
182000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
188000
CY2024Q3 us-gaap Noninterest Income
NoninterestIncome
3127000
CY2023Q3 us-gaap Noninterest Income
NoninterestIncome
1406000
CY2022Q3 us-gaap Noninterest Income
NoninterestIncome
1446000
us-gaap Noninterest Income
NoninterestIncome
2002000
us-gaap Noninterest Income
NoninterestIncome
860000
us-gaap Noninterest Income
NoninterestIncome
533000
CY2024Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
7139000
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
7524000
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6944000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
21112000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
22853000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
20395000
CY2024Q3 us-gaap Occupancy Net
OccupancyNet
2591000
CY2023Q3 us-gaap Occupancy Net
OccupancyNet
2622000
CY2022Q3 us-gaap Occupancy Net
OccupancyNet
2608000
us-gaap Occupancy Net
OccupancyNet
7764000
us-gaap Occupancy Net
OccupancyNet
7734000
us-gaap Occupancy Net
OccupancyNet
7976000
CY2024Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1681000
CY2023Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1787000
CY2022Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1520000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
5206000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
5247000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
4454000
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
618000
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
560000
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
614000
us-gaap Professional Fees
ProfessionalFees
1817000
us-gaap Professional Fees
ProfessionalFees
1748000
us-gaap Professional Fees
ProfessionalFees
1597000
CY2024Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
351000
CY2023Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
274000
CY2022Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
375000
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
882000
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
809000
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
992000
CY2024Q3 bcbp Regulatory Assessments
RegulatoryAssessments
666000
CY2023Q3 bcbp Regulatory Assessments
RegulatoryAssessments
1111000
CY2022Q3 bcbp Regulatory Assessments
RegulatoryAssessments
264000
bcbp Regulatory Assessments
RegulatoryAssessments
2761000
bcbp Regulatory Assessments
RegulatoryAssessments
2443000
bcbp Regulatory Assessments
RegulatoryAssessments
812000
CY2024Q3 us-gaap Advertising Expense
AdvertisingExpense
182000
CY2023Q3 us-gaap Advertising Expense
AdvertisingExpense
317000
CY2022Q3 us-gaap Advertising Expense
AdvertisingExpense
286000
us-gaap Advertising Expense
AdvertisingExpense
651000
us-gaap Advertising Expense
AdvertisingExpense
945000
us-gaap Advertising Expense
AdvertisingExpense
681000
CY2023Q3 bcbp Other Real Estate Owned Net
OtherRealEstateOwnedNet
1000
CY2022Q3 bcbp Other Real Estate Owned Net
OtherRealEstateOwnedNet
1000
bcbp Other Real Estate Owned Net
OtherRealEstateOwnedNet
3000
bcbp Other Real Estate Owned Net
OtherRealEstateOwnedNet
6000
CY2024Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
701000
CY2023Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1267000
CY2022Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
841000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
2561000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
2241000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
2555000
CY2024Q3 us-gaap Noninterest Expense
NoninterestExpense
13929000
CY2023Q3 us-gaap Noninterest Expense
NoninterestExpense
15463000
CY2022Q3 us-gaap Noninterest Expense
NoninterestExpense
13453000
us-gaap Noninterest Expense
NoninterestExpense
42754000
us-gaap Noninterest Expense
NoninterestExpense
44023000
us-gaap Noninterest Expense
NoninterestExpense
39468000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9353000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9418000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18944000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
21659000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32800000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47404000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2685000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2707000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5552000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6308000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9379000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13897000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
6668000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
6711000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
13392000
us-gaap Net Income Loss
NetIncomeLoss
15351000
us-gaap Net Income Loss
NetIncomeLoss
23421000
us-gaap Net Income Loss
NetIncomeLoss
33507000
CY2024Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
475000
CY2023Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
173000
CY2022Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
174000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1357000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
520000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
624000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6193000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6538000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13218000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13994000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22901000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
32883000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.94
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.82
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.89
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17039000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16830000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16982000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16991000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16868000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16986000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17064000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16854000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17356000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16992000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16951000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17369000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
6668000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
6711000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
13392000
us-gaap Net Income Loss
NetIncomeLoss
15351000
us-gaap Net Income Loss
NetIncomeLoss
23421000
us-gaap Net Income Loss
NetIncomeLoss
33507000
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
2809000
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-414000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-4191000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
2405000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-4204000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-9675000
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
692000
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-209000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-1039000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
592000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-1069000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-2398000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2117000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-205000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3152000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1813000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3135000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7277000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8785000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6506000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10240000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17164000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20286000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26230000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
314055000
us-gaap Net Income Loss
NetIncomeLoss
15351000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1813000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4720000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
626000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
1357000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.48
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
7820000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
725000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
328113000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
320732000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
6668000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2117000
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1360000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
229000
CY2024Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
475000
CY2024Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2024Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2618000
CY2024Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
100000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
328113000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
291254000
us-gaap Net Income Loss
NetIncomeLoss
23421000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3135000
bcbp Stock Issued During Period Shares Stock Option Exercised Excluding Cashless Exercises
StockIssuedDuringPeriodSharesStockOptionExercisedExcludingCashlessExercises
61000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
418000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
402000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
266753
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3816000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
520000
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
220000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.48
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
7864000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
826000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
303636000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
299623000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
6711000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-205000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
185000
CY2023Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
173000
CY2023Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
220000
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2584000
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
299000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
303636000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
274024000
us-gaap Net Income Loss
NetIncomeLoss
33507000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7277000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
458000
bcbp Stock Issued During Period Shares Stock Option Exercised Excluding Cashless Exercises
StockIssuedDuringPeriodSharesStockOptionExercisedExcludingCashlessExercises
111950
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
71513
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1998000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
624000
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
14730000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6809000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.48
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
7809000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
319000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
282682000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
271637000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
13392000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3152000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
267000
CY2022Q3 bcbp Stock Issued During Period Shares Stock Option Exercised Excluding Cashless Exercises
StockIssuedDuringPeriodSharesStockOptionExercisedExcludingCashlessExercises
111750
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000
CY2022Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
116626
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1234000
CY2022Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
174000
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4439000
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2596000
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
100000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
282682000
us-gaap Net Income Loss
NetIncomeLoss
15351000
us-gaap Net Income Loss
NetIncomeLoss
23421000
us-gaap Net Income Loss
NetIncomeLoss
33507000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
1322000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
1480000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
1735000
bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
-1191000
bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
-1835000
bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
-1005000
us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
7416000
us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
4177000
us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
-2575000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
251000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
782000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-505000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
4035000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
1528000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
5733000
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
38991000
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
1739000
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
6811000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
-4771000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
25000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
126000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
4000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
1040000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-4390000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-5546000
us-gaap Share Based Compensation
ShareBasedCompensation
626000
us-gaap Share Based Compensation
ShareBasedCompensation
402000
us-gaap Share Based Compensation
ShareBasedCompensation
458000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1998000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1154000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
2087000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
424000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
2720000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1910000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1684000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
246000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-700000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-1283000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2662000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-214000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-496000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2946000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1841000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
59941000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
34491000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32761000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
2343000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
13653000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
9310000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
10349000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
12498000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
26968000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
5024000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1232000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4000
bcbp Proceeds From Sale Of Portfolio Loans
ProceedsFromSaleOfPortfolioLoans
2014000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-145368000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
239035000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
477429000
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
3500000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
273000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4335000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
221000
us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
-185000
us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
11516000
us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
6304000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
139292000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-248707000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-496880000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-254500000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
7949000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
151544000
us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
400000000
us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
6800000
bcbp Proceeds From Federal Home Loan Bank Borrowings Short Term Net
ProceedsFromFederalHomeLoanBankBorrowingsShortTermNet
-160000000
bcbp Proceeds From Federal Home Loan Bank Borrowings Short Term Net
ProceedsFromFederalHomeLoanBankBorrowingsShortTermNet
140000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3816000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1998000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7820000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7864000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7809000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1357000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
520000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
624000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
725000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
826000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
319000
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
4720000
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
6809000
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
220000
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
14730000
us-gaap Proceeds From Issuance Of Subordinated Long Term Debt
ProceedsFromIssuanceOfSubordinatedLongTermDebt
38799000
us-gaap Repayments Of Subordinated Debt
RepaymentsOfSubordinatedDebt
9400000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
418000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-235633000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
236773000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
273514000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-36400000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22557000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-190605000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
279523000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
229359000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
411629000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
243123000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
251916000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
221024000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3429000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12322000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
13615000
us-gaap Interest Paid Net
InterestPaidNet
78812000
us-gaap Interest Paid Net
InterestPaidNet
55853000
us-gaap Interest Paid Net
InterestPaidNet
9036000
us-gaap Transfer Of Portfolio Loans And Leases To Held For Sale1
TransferOfPortfolioLoansAndLeasesToHeldForSale1
38402000
bcbp Number Of Locations
NumberOfLocations
27
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Reclassifications
Reclassifications
<span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note 3 – Reclassification </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Certain amounts have been reclassified to conform to the current period’s presentation. These changes had no effect on the Company’s results of operations or financial position.</span></p>
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
86752
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
14.98
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
50000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.44
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
50227
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
13.85
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
1725
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
14.92
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
84800
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
12.38
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
48150
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
14.83
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
52252
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.01
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
13650
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
14.60
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
86752
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
14.98
us-gaap Restricted Stock Expense
RestrictedStockExpense
519000
us-gaap Restricted Stock Expense
RestrictedStockExpense
303000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
747000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y11M4D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
975975
CY2023 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
10.55
CY2023 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.68
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
80000
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Expired Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsExpiredExercisePriceRange
13.32
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
13.32
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
895975
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
10.55
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.68
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.76
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
107000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
99000
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
434000
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
518000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
807000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
137000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6193000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17039000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6538000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16830000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13218000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16982000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
25000
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
24000
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
374000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
6193000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17064000
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
6538000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16854000
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
13218000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17356000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13994000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16991000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22901000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16868000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.36
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
32883000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16986000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.94
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
83000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
383000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
13994000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16992000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.82
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
22901000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16951000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.35
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
32883000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17369000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.89
CY2024Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
1132000
CY2023Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-436000
CY2022Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-559000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
1040000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-4157000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-5487000
CY2023Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-58000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-233000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-59000
CY2024Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
1132000
CY2023Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-494000
CY2022Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-559000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
1040000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-4390000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-5546000
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
105145000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
286000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7262000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
98169000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
97149000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
192000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
9572000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
87769000
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
76795000
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
7262000
CY2024Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
76795000
CY2024Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
7262000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
5316000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
98000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
74009000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
9474000
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
79325000
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
9572000
CY2024Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
3125647000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3317402000
CY2024Q3 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
3040000
CY2023Q4 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
4086000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
34693000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33608000
CY2024Q3 us-gaap Notes Receivable Net
NotesReceivableNet
3087914000
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
3279708000
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
35243000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
3471000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
31000
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
2890000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
34693000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
6068000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
28625000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
34693000
CY2024Q3 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
66048000
CY2024Q3 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3059599000
CY2024Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
3125647000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33608000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
6400000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
69000
us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
7416000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
34693000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
30205000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
515000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
19000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
2205000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
31914000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
2772000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
29142000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
31914000
CY2023Q3 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
35868000
CY2023Q3 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3286271000
CY2023Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
3322139000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
32373000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
555000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
84000
us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
4177000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
31914000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
32373000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
805000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
101000
CY2023 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
6104000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33608000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
4229000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
29379000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33608000
CY2023Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
54019000
CY2023Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3263383000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3317402000
CY2024Q2 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
759000
CY2023Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
694000
CY2024Q3 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
-288000
us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
-223000
CY2024Q3 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
471000
CY2024Q3 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
471000
CY2023Q2 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
254000
CY2023Q3 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
148000
us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
-864000
CY2023Q3 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
402000
CY2023Q3 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
402000
CY2024Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
3125647000
CY2024Q3 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
6220000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3317402000
bcbp Financing Receivable Modifications Number
FinancingReceivableModificationsNumber
195
us-gaap Financing Receivable Excluding Accrued Interest Modified Period
FinancingReceivableExcludingAccruedInterestModifiedPeriod
43201000
us-gaap Financing Receivable Modification To Total Financing Receivables Percent
FinancingReceivableModificationToTotalFinancingReceivablesPercent
0.0138
CY2024Q3 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
43201000
CY2024Q3 bcbp Financing Receivable Non Accrual With Allowance
FinancingReceivableNonAccrualWithAllowance
11855000
CY2024Q3 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
23475000
CY2024Q3 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
35330000
CY2024Q3 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
6220000
CY2023Q4 bcbp Financing Receivable Non Accrual With Allowance
FinancingReceivableNonAccrualWithAllowance
6940000
CY2023Q4 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
11843000
CY2023Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
18783000
us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
5000000.0
CY2023 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
1900000
bcbp Loans And Leases Receivable Loans Returned To Accrual Interest Income
LoansAndLeasesReceivableLoansReturnedToAccrualInterestIncome
1100000
CY2023 bcbp Loans And Leases Receivable Loans Returned To Accrual Interest Income
LoansAndLeasesReceivableLoansReturnedToAccrualInterestIncome
314000
CY2024Q3 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
6200000
CY2023Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2024Q3 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
10248000
CY2024Q3 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
285409000
CY2024Q3 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
900452000
CY2024Q3 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
319537000
CY2024Q3 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
232831000
CY2024Q3 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
992745000
CY2024Q3 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
338812000
CY2024Q3 us-gaap Financing Receivable Revolving Converted To Term Loan
FinancingReceivableRevolvingConvertedToTermLoan
45613000
CY2024Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
3125647000
us-gaap Financing Receivable Year One Originated Current Fiscal Year Writeoff
FinancingReceivableYearOneOriginatedCurrentFiscalYearWriteoff
446000
us-gaap Financing Receivable Originated More Than Five Years Before Current Fiscal Year Writeoff
FinancingReceivableOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteoff
567000
us-gaap Financing Receivable Revolving Writeoff
FinancingReceivableRevolvingWriteoff
5206000
us-gaap Financing Receivable Revolving Converted To Term Loan Writeoff
FinancingReceivableRevolvingConvertedToTermLoanWriteoff
181000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
6400000
CY2023Q4 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
280851000
CY2023Q4 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
959372000
CY2023Q4 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
333030000
CY2023Q4 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
276923000
CY2023Q4 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
72067000
CY2023Q4 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
1021468000
CY2023Q4 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
372776000
CY2023Q4 us-gaap Financing Receivable Revolving Converted To Term Loan
FinancingReceivableRevolvingConvertedToTermLoan
915000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3317402000
CY2023 us-gaap Financing Receivable Revolving Writeoff
FinancingReceivableRevolvingWriteoff
805000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
805000
CY2024Q3 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
75400000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
CY2023Q3 bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
CY2024Q3 bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
CY2018Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
33500000
CY2024Q3 us-gaap Debt Instrument Repurchase Amount
DebtInstrumentRepurchaseAmount
9400000
bcbp Lessee Operating Leases Number
LesseeOperatingLeasesNumber
24
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
904000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
878000
us-gaap Operating Lease Cost
OperatingLeaseCost
2690000
us-gaap Operating Lease Cost
OperatingLeaseCost
2710000
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
280000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
269000
us-gaap Variable Lease Cost
VariableLeaseCost
829000
us-gaap Variable Lease Cost
VariableLeaseCost
793000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13438000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12935000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
852000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3094000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14487000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11526000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1461000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1305000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
13878000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13315000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M18D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y9M7D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0338
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0302
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
852000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3094000
CY2024Q3 bcbp Lessee Operating Lease Liability Payments Year One To Year Three
LesseeOperatingLeaseLiabilityPaymentsYearOneToYearThree
6141000
CY2023Q4 bcbp Lessee Operating Lease Liability Payments Year One To Year Three
LesseeOperatingLeaseLiabilityPaymentsYearOneToYearThree
5132000
CY2024Q3 bcbp Lessee Operating Lease Liability Payments Year Three To Year Five
LesseeOperatingLeaseLiabilityPaymentsYearThreeToYearFive
4666000
CY2023Q4 bcbp Lessee Operating Lease Liability Payments Year Three To Year Five
LesseeOperatingLeaseLiabilityPaymentsYearThreeToYearFive
3632000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3680000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2762000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
15339000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14620000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1461000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1305000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
13878000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13315000

Files In Submission

Name View Source Status
0001228454-24-000012-index-headers.html Edgar Link pending
0001228454-24-000012-index.html Edgar Link pending
0001228454-24-000012.txt Edgar Link pending
0001228454-24-000012-xbrl.zip Edgar Link pending
bcbp-20240930.xsd Edgar Link pending
bcbp-20240930x10q.htm Edgar Link pending
bcbp-20240930xex31_1.htm Edgar Link pending
bcbp-20240930xex31_2.htm Edgar Link pending
bcbp-20240930xex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
bcbp-20240930_cal.xml Edgar Link unprocessable
bcbp-20240930_def.xml Edgar Link unprocessable
bcbp-20240930_pre.xml Edgar Link unprocessable
bcbp-20240930_lab.xml Edgar Link unprocessable
bcbp-20240930x10q_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable